Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NKCC1 ELISA Kit (AC3663)
Cat.#: ASET-2252
Specifications
Description Human NKCC1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NKCC1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 11.49 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1042 Human Pannexin 1 ELISA Kit (AC2453) Quantitative inquiry ASET-2127 Human NDRG1 ELISA Kit (AC3538) Quantitative inquiry ASET-1437 Human Wnt3 ELISA Kit (AC2848) Quantitative inquiry ASET-1059 Human HMT ELISA Kit (AC2470) Quantitative inquiry ASET-2405 Human Neuritin ELISA Kit (AC3816) Quantitative inquiry ASET-2194 Guinea Pig Adiponectin ELISA Kit (AC3605) Quantitative inquiry ASET-2416 Human SRD5A1 ELISA Kit (AC3827) Quantitative inquiry ASET-1079 Human Synapsin I ELISA Kit (AC2490) Quantitative inquiry ASET-2010 Human SEMA3D ELISA Kit (AC3421) Quantitative inquiry ASET-1879 Mouse TIMP3 ELISA Kit (AC3290) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket